カテゴリー： 世界, 医療/バイオ, GlobalInfoResearch

世界の標的DNA修復薬市場2023年：企業・地域・タイプ・用途別分析

【英語タイトル】Global Targeting DNA Repair Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが出版した調査資料（GIR23SM7988）・商品コード：GIR23SM7988
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2023年9月（※2025年版があります。お問い合わせください。）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（注文後2-3日）
・調査対象地域：グローバル
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の標的DNA修復薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の標的DNA修復薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 標的DNA修復薬の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

標的DNA修復薬市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・オラパリブ、ルカパリブ、ニラパリブ、タラゾパリブ、その他

用途別セグメント
・卵巣がん、卵管がん、腹膜がん、乳がん、その他

主要な市場プレーヤー
・Onxeo、FoRx Therapeutics、Artios Pharma Limited、Merck KGaA、Breakpoint Therapeutics、Luciole Pharmaceuticals、AstraZeneca、AbbVie、Johnson & Johnson、Pfizer、ClovisOncology、GlaxoSmithKline

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、標的DNA修復薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な標的DNA修復薬メーカーの企業概要、2019年～2022年までの標的DNA修復薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な標的DNA修復薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別標的DNA修復薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの標的DNA修復薬のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での標的DNA修復薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および標的DNA修復薬の産業チェーンを掲載しています。
・第14、15章では、標的DNA修復薬の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 標的DNA修復薬の概要
– タイプ別分析（2018年vs2022年vs2029年）：オラパリブ、ルカパリブ、ニラパリブ、タラゾパリブ、その他
– 用途別分析（2018年vs2022年vs2029年）：卵巣がん、卵管がん、腹膜がん、乳がん、その他
– 世界の標的DNA修復薬市場規模・予測
– 世界の標的DNA修復薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Onxeo、FoRx Therapeutics、Artios Pharma Limited、Merck KGaA、Breakpoint Therapeutics、Luciole Pharmaceuticals、AstraZeneca、AbbVie、Johnson & Johnson、Pfizer、ClovisOncology、GlaxoSmithKline
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：オラパリブ、ルカパリブ、ニラパリブ、タラゾパリブ、その他
・用途別分析2018年-2029年：卵巣がん、卵管がん、腹膜がん、乳がん、その他
・標的DNA修復薬の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・標的DNA修復薬のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・標的DNA修復薬のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・標的DNA修復薬の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・標的DNA修復薬の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Targeting DNA Repair Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Targeting DNA Repair Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Olaparib
1.3.3 Rucaparib
1.3.4 Niraparib
1.3.5 Talazoparib
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Targeting DNA Repair Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Ovarian Cancer
1.4.3 Fallopian Tube Cancer
1.4.4 Peritoneal Cancer
1.4.5 Breast Cancer
1.4.6 Others
1.5 Global Targeting DNA Repair Drugs Market Size & Forecast
1.5.1 Global Targeting DNA Repair Drugs Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Targeting DNA Repair Drugs Sales Quantity (2018-2029)
1.5.3 Global Targeting DNA Repair Drugs Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Onxeo
2.1.1 Onxeo Details
2.1.2 Onxeo Major Business
2.1.3 Onxeo Targeting DNA Repair Drugs Product and Services
2.1.4 Onxeo Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Onxeo Recent Developments/Updates
2.2 FoRx Therapeutics
2.2.1 FoRx Therapeutics Details
2.2.2 FoRx Therapeutics Major Business
2.2.3 FoRx Therapeutics Targeting DNA Repair Drugs Product and Services
2.2.4 FoRx Therapeutics Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 FoRx Therapeutics Recent Developments/Updates
2.3 Artios Pharma Limited
2.3.1 Artios Pharma Limited Details
2.3.2 Artios Pharma Limited Major Business
2.3.3 Artios Pharma Limited Targeting DNA Repair Drugs Product and Services
2.3.4 Artios Pharma Limited Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Artios Pharma Limited Recent Developments/Updates
2.4 Merck KGaA
2.4.1 Merck KGaA Details
2.4.2 Merck KGaA Major Business
2.4.3 Merck KGaA Targeting DNA Repair Drugs Product and Services
2.4.4 Merck KGaA Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Merck KGaA Recent Developments/Updates
2.5 Breakpoint Therapeutics
2.5.1 Breakpoint Therapeutics Details
2.5.2 Breakpoint Therapeutics Major Business
2.5.3 Breakpoint Therapeutics Targeting DNA Repair Drugs Product and Services
2.5.4 Breakpoint Therapeutics Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Breakpoint Therapeutics Recent Developments/Updates
2.6 Luciole Pharmaceuticals
2.6.1 Luciole Pharmaceuticals Details
2.6.2 Luciole Pharmaceuticals Major Business
2.6.3 Luciole Pharmaceuticals Targeting DNA Repair Drugs Product and Services
2.6.4 Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Luciole Pharmaceuticals Recent Developments/Updates
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business
2.7.3 AstraZeneca Targeting DNA Repair Drugs Product and Services
2.7.4 AstraZeneca Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 AstraZeneca Recent Developments/Updates
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Targeting DNA Repair Drugs Product and Services
2.8.4 AbbVie Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AbbVie Recent Developments/Updates
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson Targeting DNA Repair Drugs Product and Services
2.9.4 Johnson & Johnson Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Johnson & Johnson Recent Developments/Updates
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Targeting DNA Repair Drugs Product and Services
2.10.4 Pfizer Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pfizer Recent Developments/Updates
2.11 ClovisOncology
2.11.1 ClovisOncology Details
2.11.2 ClovisOncology Major Business
2.11.3 ClovisOncology Targeting DNA Repair Drugs Product and Services
2.11.4 ClovisOncology Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 ClovisOncology Recent Developments/Updates
2.12 GlaxoSmithKline
2.12.1 GlaxoSmithKline Details
2.12.2 GlaxoSmithKline Major Business
2.12.3 GlaxoSmithKline Targeting DNA Repair Drugs Product and Services
2.12.4 GlaxoSmithKline Targeting DNA Repair Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 GlaxoSmithKline Recent Developments/Updates
3 Competitive Environment: Targeting DNA Repair Drugs by Manufacturer
3.1 Global Targeting DNA Repair Drugs Sales Quantity by Manufacturer (2018-2023)
3.2 Global Targeting DNA Repair Drugs Revenue by Manufacturer (2018-2023)
3.3 Global Targeting DNA Repair Drugs Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Targeting DNA Repair Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Targeting DNA Repair Drugs Manufacturer Market Share in 2022
3.4.2 Top 6 Targeting DNA Repair Drugs Manufacturer Market Share in 2022
3.5 Targeting DNA Repair Drugs Market: Overall Company Footprint Analysis
3.5.1 Targeting DNA Repair Drugs Market: Region Footprint
3.5.2 Targeting DNA Repair Drugs Market: Company Product Type Footprint
3.5.3 Targeting DNA Repair Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Targeting DNA Repair Drugs Market Size by Region
4.1.1 Global Targeting DNA Repair Drugs Sales Quantity by Region (2018-2029)
4.1.2 Global Targeting DNA Repair Drugs Consumption Value by Region (2018-2029)
4.1.3 Global Targeting DNA Repair Drugs Average Price by Region (2018-2029)
4.2 North America Targeting DNA Repair Drugs Consumption Value (2018-2029)
4.3 Europe Targeting DNA Repair Drugs Consumption Value (2018-2029)
4.4 Asia-Pacific Targeting DNA Repair Drugs Consumption Value (2018-2029)
4.5 South America Targeting DNA Repair Drugs Consumption Value (2018-2029)
4.6 Middle East and Africa Targeting DNA Repair Drugs Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
5.2 Global Targeting DNA Repair Drugs Consumption Value by Type (2018-2029)
5.3 Global Targeting DNA Repair Drugs Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
6.2 Global Targeting DNA Repair Drugs Consumption Value by Application (2018-2029)
6.3 Global Targeting DNA Repair Drugs Average Price by Application (2018-2029)
7 North America
7.1 North America Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
7.2 North America Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
7.3 North America Targeting DNA Repair Drugs Market Size by Country
7.3.1 North America Targeting DNA Repair Drugs Sales Quantity by Country (2018-2029)
7.3.2 North America Targeting DNA Repair Drugs Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
8.2 Europe Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
8.3 Europe Targeting DNA Repair Drugs Market Size by Country
8.3.1 Europe Targeting DNA Repair Drugs Sales Quantity by Country (2018-2029)
8.3.2 Europe Targeting DNA Repair Drugs Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Targeting DNA Repair Drugs Market Size by Region
9.3.1 Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Targeting DNA Repair Drugs Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
10.2 South America Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
10.3 South America Targeting DNA Repair Drugs Market Size by Country
10.3.1 South America Targeting DNA Repair Drugs Sales Quantity by Country (2018-2029)
10.3.2 South America Targeting DNA Repair Drugs Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Targeting DNA Repair Drugs Market Size by Country
11.3.1 Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Targeting DNA Repair Drugs Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Targeting DNA Repair Drugs Market Drivers
12.2 Targeting DNA Repair Drugs Market Restraints
12.3 Targeting DNA Repair Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Targeting DNA Repair Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Targeting DNA Repair Drugs
13.3 Targeting DNA Repair Drugs Production Process
13.4 Targeting DNA Repair Drugs Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Targeting DNA Repair Drugs Typical Distributors
14.3 Targeting DNA Repair Drugs Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Targeting DNA Repair Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Targeting DNA Repair Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Onxeo Basic Information, Manufacturing Base and Competitors
Table 4. Onxeo Major Business
Table 5. Onxeo Targeting DNA Repair Drugs Product and Services
Table 6. Onxeo Targeting DNA Repair Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Onxeo Recent Developments/Updates
Table 8. FoRx Therapeutics Basic Information, Manufacturing Base and Competitors
Table 9. FoRx Therapeutics Major Business
Table 10. FoRx Therapeutics Targeting DNA Repair Drugs Product and Services
Table 11. FoRx Therapeutics Targeting DNA Repair Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. FoRx Therapeutics Recent Developments/Updates
Table 13. Artios Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 14. Artios Pharma Limited Major Business
Table 15. Artios Pharma Limited Targeting DNA Repair Drugs Product and Services
Table 16. Artios Pharma Limited Targeting DNA Repair Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Artios Pharma Limited Recent Developments/Updates
Table 18. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 19. Merck KGaA Major Business
Table 20. Merck KGaA Targeting DNA Repair Drugs Product and Services
Table 21. Merck KGaA Targeting DNA Repair Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Merck KGaA Recent Developments/Updates
Table 23. Breakpoint Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Breakpoint Therapeutics Major Business
Table 25. Breakpoint Therapeutics Targeting DNA Repair Drugs Product and Services
Table 26. Breakpoint Therapeutics Targeting DNA Repair Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Breakpoint Therapeutics Recent Developments/Updates
Table 28. Luciole Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Luciole Pharmaceuticals Major Business
Table 30. Luciole Pharmaceuticals Targeting DNA Repair Drugs Product and Services
Table 31. Luciole Pharmaceuticals Targeting DNA Repair Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Luciole Pharmaceuticals Recent Developments/Updates
Table 33. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 34. AstraZeneca Major Business
Table 35. AstraZeneca Targeting DNA Repair Drugs Product and Services
Table 36. AstraZeneca Targeting DNA Repair Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. AstraZeneca Recent Developments/Updates
Table 38. AbbVie Basic Information, Manufacturing Base and Competitors
Table 39. AbbVie Major Business
Table 40. AbbVie Targeting DNA Repair Drugs Product and Services
Table 41. AbbVie Targeting DNA Repair Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. AbbVie Recent Developments/Updates
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Major Business
Table 45. Johnson & Johnson Targeting DNA Repair Drugs Product and Services
Table 46. Johnson & Johnson Targeting DNA Repair Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Johnson & Johnson Recent Developments/Updates
Table 48. Pfizer Basic Information, Manufacturing Base and Competitors
Table 49. Pfizer Major Business
Table 50. Pfizer Targeting DNA Repair Drugs Product and Services
Table 51. Pfizer Targeting DNA Repair Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Pfizer Recent Developments/Updates
Table 53. ClovisOncology Basic Information, Manufacturing Base and Competitors
Table 54. ClovisOncology Major Business
Table 55. ClovisOncology Targeting DNA Repair Drugs Product and Services
Table 56. ClovisOncology Targeting DNA Repair Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. ClovisOncology Recent Developments/Updates
Table 58. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 59. GlaxoSmithKline Major Business
Table 60. GlaxoSmithKline Targeting DNA Repair Drugs Product and Services
Table 61. GlaxoSmithKline Targeting DNA Repair Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. GlaxoSmithKline Recent Developments/Updates
Table 63. Global Targeting DNA Repair Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Targeting DNA Repair Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Targeting DNA Repair Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Targeting DNA Repair Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Targeting DNA Repair Drugs Production Site of Key Manufacturer
Table 68. Targeting DNA Repair Drugs Market: Company Product Type Footprint
Table 69. Targeting DNA Repair Drugs Market: Company Product Application Footprint
Table 70. Targeting DNA Repair Drugs New Market Entrants and Barriers to Market Entry
Table 71. Targeting DNA Repair Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Targeting DNA Repair Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Targeting DNA Repair Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Targeting DNA Repair Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Targeting DNA Repair Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Targeting DNA Repair Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Targeting DNA Repair Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Targeting DNA Repair Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Targeting DNA Repair Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Targeting DNA Repair Drugs Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Targeting DNA Repair Drugs Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Targeting DNA Repair Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Targeting DNA Repair Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Targeting DNA Repair Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Targeting DNA Repair Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Targeting DNA Repair Drugs Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Targeting DNA Repair Drugs Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Targeting DNA Repair Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Targeting DNA Repair Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Targeting DNA Repair Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Targeting DNA Repair Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Targeting DNA Repair Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Targeting DNA Repair Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Targeting DNA Repair Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Targeting DNA Repair Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Targeting DNA Repair Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Targeting DNA Repair Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Targeting DNA Repair Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Targeting DNA Repair Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Targeting DNA Repair Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Targeting DNA Repair Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Targeting DNA Repair Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Targeting DNA Repair Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Targeting DNA Repair Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Targeting DNA Repair Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Targeting DNA Repair Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Targeting DNA Repair Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Targeting DNA Repair Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Targeting DNA Repair Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Targeting DNA Repair Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Targeting DNA Repair Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Targeting DNA Repair Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Targeting DNA Repair Drugs Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Targeting DNA Repair Drugs Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Targeting DNA Repair Drugs Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Targeting DNA Repair Drugs Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Targeting DNA Repair Drugs Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Targeting DNA Repair Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Targeting DNA Repair Drugs Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Targeting DNA Repair Drugs Raw Material
Table 131. Key Manufacturers of Targeting DNA Repair Drugs Raw Materials
Table 132. Targeting DNA Repair Drugs Typical Distributors
Table 133. Targeting DNA Repair Drugs Typical Customers
List of Figures
Figure 1. Targeting DNA Repair Drugs Picture
Figure 2. Global Targeting DNA Repair Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Targeting DNA Repair Drugs Consumption Value Market Share by Type in 2022
Figure 4. Olaparib Examples
Figure 5. Rucaparib Examples
Figure 6. Niraparib Examples
Figure 7. Talazoparib Examples
Figure 8. Others Examples
Figure 9. Global Targeting DNA Repair Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global Targeting DNA Repair Drugs Consumption Value Market Share by Application in 2022
Figure 11. Ovarian Cancer Examples
Figure 12. Fallopian Tube Cancer Examples
Figure 13. Peritoneal Cancer Examples
Figure 14. Breast Cancer Examples
Figure 15. Others Examples
Figure 16. Global Targeting DNA Repair Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Targeting DNA Repair Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Targeting DNA Repair Drugs Sales Quantity (2018-2029) & (K Units)
Figure 19. Global Targeting DNA Repair Drugs Average Price (2018-2029) & (US$/Unit)
Figure 20. Global Targeting DNA Repair Drugs Sales Quantity Market Share by Manufacturer in 2022
Figure 21. Global Targeting DNA Repair Drugs Consumption Value Market Share by Manufacturer in 2022
Figure 22. Producer Shipments of Targeting DNA Repair Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 23. Top 3 Targeting DNA Repair Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Top 6 Targeting DNA Repair Drugs Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Global Targeting DNA Repair Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 26. Global Targeting DNA Repair Drugs Consumption Value Market Share by Region (2018-2029)
Figure 27. North America Targeting DNA Repair Drugs Consumption Value (2018-2029) & (USD Million)
Figure 28. Europe Targeting DNA Repair Drugs Consumption Value (2018-2029) & (USD Million)
Figure 29. Asia-Pacific Targeting DNA Repair Drugs Consumption Value (2018-2029) & (USD Million)
Figure 30. South America Targeting DNA Repair Drugs Consumption Value (2018-2029) & (USD Million)
Figure 31. Middle East & Africa Targeting DNA Repair Drugs Consumption Value (2018-2029) & (USD Million)
Figure 32. Global Targeting DNA Repair Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 33. Global Targeting DNA Repair Drugs Consumption Value Market Share by Type (2018-2029)
Figure 34. Global Targeting DNA Repair Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 35. Global Targeting DNA Repair Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 36. Global Targeting DNA Repair Drugs Consumption Value Market Share by Application (2018-2029)
Figure 37. Global Targeting DNA Repair Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 38. North America Targeting DNA Repair Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 39. North America Targeting DNA Repair Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 40. North America Targeting DNA Repair Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 41. North America Targeting DNA Repair Drugs Consumption Value Market Share by Country (2018-2029)
Figure 42. United States Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Canada Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Mexico Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Europe Targeting DNA Repair Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 46. Europe Targeting DNA Repair Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 47. Europe Targeting DNA Repair Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 48. Europe Targeting DNA Repair Drugs Consumption Value Market Share by Country (2018-2029)
Figure 49. Germany Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. France Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. United Kingdom Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Russia Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Italy Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Asia-Pacific Targeting DNA Repair Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 55. Asia-Pacific Targeting DNA Repair Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 56. Asia-Pacific Targeting DNA Repair Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 57. Asia-Pacific Targeting DNA Repair Drugs Consumption Value Market Share by Region (2018-2029)
Figure 58. China Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Japan Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Korea Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. India Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Southeast Asia Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Australia Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. South America Targeting DNA Repair Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 65. South America Targeting DNA Repair Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 66. South America Targeting DNA Repair Drugs Sales Quantity Market Share by Country (2018-2029)
Figure 67. South America Targeting DNA Repair Drugs Consumption Value Market Share by Country (2018-2029)
Figure 68. Brazil Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Argentina Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Middle East & Africa Targeting DNA Repair Drugs Sales Quantity Market Share by Type (2018-2029)
Figure 71. Middle East & Africa Targeting DNA Repair Drugs Sales Quantity Market Share by Application (2018-2029)
Figure 72. Middle East & Africa Targeting DNA Repair Drugs Sales Quantity Market Share by Region (2018-2029)
Figure 73. Middle East & Africa Targeting DNA Repair Drugs Consumption Value Market Share by Region (2018-2029)
Figure 74. Turkey Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Egypt Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Saudi Arabia Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. South Africa Targeting DNA Repair Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. Targeting DNA Repair Drugs Market Drivers
Figure 79. Targeting DNA Repair Drugs Market Restraints
Figure 80. Targeting DNA Repair Drugs Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Targeting DNA Repair Drugs in 2022
Figure 83. Manufacturing Process Analysis of Targeting DNA Repair Drugs
Figure 84. Targeting DNA Repair Drugs Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source


★調査レポート[世界の標的DNA修復薬市場2023年：企業・地域・タイプ・用途別分析] (コード：GIR23SM7988)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の標的DNA修復薬市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の胸部手術修復パッチ市場2023年：企業・地域・タイプ・用途別分析
  • 世界の角膜修復製品市場2023年：企業・地域・タイプ・用途別分析
  • 世界のシリコーン製傷修理ステッカー市場2023年：企業・地域・タイプ・用途別分析
  • 世界の自動車修理用作業台市場2023年：企業・地域・タイプ・用途別分析
  • 世界の軽量補修モルタル市場2023年：企業・地域・タイプ・用途別分析
  • 世界の歯科用迅速修繕充填粉末市場2023年：企業・地域・タイプ・用途別分析
  • 世界の角膜修復薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界のかゆみ止め薬市場2023年：企業・地域・タイプ・用途別分析
  • 世界の前立腺がんPARP阻害剤市場2023年：企業・地域・タイプ・用途別分析
  • 世界の抗呼吸器合胞体（RS)ウイルス薬市場2023年：企業・地域・タイプ・用途別分析

    • ◆H&Iグローバルリサーチのお客様（例）◆